Table 1.
Detailed information on twenty C. difficile negative horses studied via high-throughput amplicons sequencing analysis with and without diarrhoea
| Clinical history of horses | |||||||
|---|---|---|---|---|---|---|---|
| Date of sampling | Animal number | Age (years) | Diagnostic | Diarrhea | Hospital stay (days) | Antibiotic treatment (days) 1 | NSAIDs treatment |
| 9/10/13 | 13 | 12 | Colic | + | 5 | Pen-Gen (1)2 | F-M |
| 21/10/13 | 14 | 3 | Diarrhoea | + | 3 | - | - |
| 28/10/13 | 15 | 21 | Diarrhoea and colic | + | 2 | SXT (2) | F-M |
| 5/11/13 | 17 | 13 | Equine atypical myopathy | + | 1 | - | - |
| 18/11/13 | 23 | 9 | Diarrhoea and colic | + | 1 | - | Dipyrone |
| 18/11/13 | 25 | 2 | Haemorrhagic enterocolitis | + | 1 | - | - |
| Hyperlipemia | |||||||
| 22/11/13 | 26 | 5 | Diarrhoea and weight loss | + | 1 | Xnl (1) | F-M |
| Dipyrone | |||||||
| 26/11/13 | 27 | 6 | Colic | + | 2 | - | F-M |
| 26/11/13 | 28 | 11 | Colic | + | 4 | Pen-Gen-LZ (1)2 | F-M |
| Dipyrone | |||||||
| Firocoxib | |||||||
| 19/12/13 | 29 | 2 | Diarrhoea | + | 2 | - | - |
| 8/10/13 | 11 | 11 | Oesophageal obstruction | - | 1 | Pen-Gen-LZ (1)2 | F-M |
| 9/10/13 | 12 | 8 | Horse fall | - | 10 | Xnl (7)2 | Dipyrone |
| 28/10/13 | 16 | 21 | Wound | - | 3 | SXT (4)2 | Dipyrone |
| 7/11/13 | 18 | 8 | Equine atypical myopathy | - | 1 | - | - |
| 8/11/13 | 19 | 6 | Colic | - | 1 | - | - |
| 12/11/13 | 20 | 6 | Colic | - | 1 | - | F-M |
| 13/11/13 | 21 | 5 | Equine atypical myopathy | - | 1 | - | - |
| 18/11/13 | 22 | 3 | Osteochondritis dissecans screening | - | 1 | - | - |
| 18/11/13 | 24 | 9 | Colic | - | 2 | Pen-Gen (2)2 | F-M |
| 19/12/13 | 30 | 2 | Arthroscopy | - | 3 | - | - |
NSAIDs nonsteroidal anti-inflamatory dugs
Pen penicillin, Gen gentamicin, Xnl ceftiofur, SXT trimethoprim/sulfamethoxazole, LZ metronidazole
F-M Flunixin meglumine
1Time before antibiotic administration in days 2Antibiotic treatment in progress at the time of sampling